MADRID, Feb 21 (Reuters) - Steven F. Mayer has resigned as executive chairman of the board of Spanish pharmaceutical company Grifols, the company said on Tuesday, citing health reasons. (Reporting by David Latona; Editing by Andrei Khalip)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.951 EUR | -2.25% | +6.17% | -35.68% |
05-15 | GRIFOLS : In line Q1 and on track deleveraging; worth a go | |
05-14 | Grifols, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.68% | 6.63B | |
+0.10% | 91.42B | |
+2.76% | 41.08B | |
-9.06% | 34.26B | |
+54.56% | 25.27B | |
-16.61% | 15.27B | |
-9.14% | 12.81B | |
-12.11% | 11.6B | |
-43.61% | 11.42B | |
+5.39% | 9.16B |
- Stock Market
- Equities
- GRF Stock
- News Grifols, S.A.
- Executive chairman of Spanish pharma company Grifols resigns